Testing the MultiSense Non-Invasive Device for Blood Pressure and Vital Sign Monitoring in ICU Patients

What this Trial Is About

Researchers are evaluating a new non-invasive device called MultiSense designed to monitor blood pressure and other vital signs in intensive care unit ICU patients. This study compares the devices readings with standard invasive methods to assess accuracy. The goal is to improve patient safety and comfort while helping doctors detect issues earlier by monitoring blood pressure, microcirculation, central body temperature, and heart rhythm. The study involves using the MultiSense device, a wireless system applied to ICU patients who already have invasive catheters for blood pressure and temperature monitoring. The device continuously collects vital sign data and uses intelligent algorithms to reduce false alarms and enhance patient mobility. The study is non-randomized and does not involve placebo or masking. Participants will be adult ICU patients expected to stay more than two days and equipped with arterial and urinary catheters. Researchers will monitor agreement between the non-invasive blood pressure readings from MultiSense and invasive measurements over seven days. Safety, comfort, and data accuracy will be evaluated through continuous monitoring during the ICU stay. The study lasts from March 2025 to March 2028.

Non-Invasive Blood Pressure Monitoring in ICU Patients Using the DARE Device